We offer a full range of viral vector gene therapy services:

• For suspension-based vector production, we have capacity for culture volumes of 20 to 200L using single-use bioreactors provided by GE/Xcellerex.
• Our adherent cell-based vector production suite houses the full range of cutting-edge technologies, including CellSTACK^®-10, HYPERStack^®-36 and iCELLis^® fixed-bioreactors.
• Vibalogics’ platform for AAV vector production comprises an affinity-chromatography system and a range of filtration technologies, including depth, cross-flow and sterile filtration.
• All open step vector production operations are performed in GMP class A/B suites in line with European GMP guidelines. Purification is performed in class C suites.